Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer [Phase 2]
Phase 2 clinical trial update on the Triple-B study comparing carboplatin-cyclophosphamide versus paclitaxel with or without atezolizumab as…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients [Phase 4]
A Phase 4 clinical trial compares AI-assisted screening mammography to standard screening without AI to evaluate cancer detection and recall…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Basket Study for Oligo-metastatic Breast Cancer [Phase 2]
Phase 2 basket trial evaluating therapies for oligo-metastatic HER2-positive breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation.
A clinical trial evaluating combined low-pass whole-genome sequencing and methylome testing of bloody nipple discharge to differentiate beni…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer [Phase 2]
A Phase 2 trial is investigating whether pegfilgrastim affects trastuzumab’s anti-tumor activity and ADCC in operable HER2-positive breast c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
An ongoing real-world study evaluating a Trop-2–targeting antibody-drug conjugate in breast cancer patients with brain metastases, sponsored…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating a PEG-G-CSF injection to prevent chemotherapy-induced neutropenia, with status listed as active but not re…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Confocal Histolog Scanner in Routine Breast-Conserving Surgery (CHiB) [NA]
Clinical trial update for the CHiB study evaluating a Confocal Histolog Scanner used in routine breast-conserving surgery. The trial is curr…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
This clinical trial update describes a real-world study of palbociclib use and its effects in US patients with breast cancer. The study is s…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Women Informed to Screen Depending on Measures of Risk (Wisdom Study) [NA]
Clinical trial update for the Wisdom study on risk-based breast cancer screening; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies [Phase 2]
An update indicating that participants from Pfizer-sponsored Palbociclib Phase 2 studies may continue participation; the trial remains activ…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Characterization of Extracellular Vesicles in Breast Cancer Patients
A clinical trial update describes a study on the characterization of extracellular vesicles in patients with breast cancer. The sponsor is I…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: BREAST Choice Decision Tool R21 - AIM2 [NA]
Clinical trial update for a breast cancer study evaluating the BREAST Choice Decision Tool (R21 - AIM2). The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Inavolisib Plus Pertuzumab and Trastuzumab as Subcutaneous (PH-FDC SC) and 3-week Cycle Nab-paclitaxel for PIK3CA-mutated, HER2+, eBC [Phase 2]
This is a Phase II, multicenter, open-label neoadjuvant trial evaluating Inavolisib with Pertuzumab and Trastuzumab plus Nab-paclitaxel for …
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients [Phase 1]
This is a Phase 1 trial update studying oral OP-1250 in combination with palbociclib for hormone receptor-positive, HER2-negative breast can…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: WashU DIEP Flap Video and Patient Understanding Improvement [NA]
A Washington University trial evaluating a DIEP flap surgical video to improve patient understanding in breast cancer patients; the study is…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer [Phase 4]
Phase 4 clinical trial updating on the use of the PET tracer [18F]-FES to image estrogen receptor–positive breast cancer with brain metastas…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients [Phase 2]
This update describes a Phase 2 clinical trial evaluating dapagliflozin for primary prevention of cardiotoxicity from anthracycline chemothe…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: MRg-NIRS Imaging System Breast Cancer Trial [NA]
A clinical trial evaluating MR-guided near-infrared spectroscopy (MRg-NIRS) imaging for breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer [Phase 2]
A Phase 2 clinical trial is testing olaparib alone or in combination with atezolizumab in BRCA-mutant, non-HER2-positive breast cancer, with…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: The Preoperative Health & Body Study [NA]
The Preoperative Health & Body Study for breast cancer is currently active but not recruiting, sponsored by Dana-Farber Cancer Institute.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Shaving as an Safe Alternative to Frozen Section Analysis [NA]
A clinical trial is evaluating shaving as a safe alternative to frozen section analysis in early stage breast cancer; the study is not yet r…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue [NA]
Dana-Farber Cancer Institute is sponsoring a clinical trial examining the effects of physical activity on cellular proliferation and immune …
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Moderate-Intensity Exercise and Pain Sensitization in Breast Cancer Survivors: A Case-Based Study [NA]
A case-based clinical trial update examining the effects of moderate-intensity exercise on pain sensitization in breast cancer survivors. Th…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York [NA]
This study evaluates a post-treatment supportive service program to help Black women breast cancer survivors transition into survivorship in…